Project description
Harnessing artificial intelligence to predict genetic risk for common and rare diseases
Different people develop disease and respond to treatments differently. Moving away from the one-size-fits-all approach, personalised medicine pursues treatment options tailored to the genetic profile of individuals. The EU-funded INTERVENE project will develop next-generation tools for disease prevention, diagnosis and personalised treatment. INTERVENE will use powerful artificial intelligence technologies on a vast and diverse US-European pool of genomic and health data to calculate genetic risk scores that predict an individual’s susceptibility to a particular disease. The risk scores will be tested in clinical trials focusing on devastating common diseases, such as diabetes, cancer, and cardiovascular disease. INTERVENE will also develop and test the role of risk scores in several rare diseases as well as COVID-19 infection and severity.
Fields of science
Programme(s)
Funding Scheme
RIA - Research and Innovation action
Coordinator
00014 Helsingin Yliopisto
Finland
See on map
Participants (17)
Participation ended
8803 Rueschlikon
69117 Heidelberg
See on map
53100 Siena
See on map
7491 Trondheim
See on map
51005 Tartu
See on map
8010 Graz
See on map
80333 Muenchen
See on map
02101 Espoo
See on map
14482 Potsdam
See on map
02150 Espoo
See on map
00029 Helsinki
See on map
CB2 1TN Cambridge
See on map
02114 Boston Ma
See on map
10124 Torino
See on map
1210 Bruxelles
See on map
2289 DC Rijswijk
See on map
E1 4NS London
See on map